Azmacort, or Triamcinolone, is one of a group of Inhalation Corticosteroids used to help prevent the symptoms of asthma. When used regularly, inhalation corticosteroids decrease the number and severity of asthma attacks, but will not relieve an asthma attack that has already started.
Be sure to tell your doctor of any allergies you have whether it is to medication or food, preservatives, or dyes. Also, tell your doctor of any other medications you are taking, including vitamins and supplements, and any medical conditions you may have.
It is very important that you take this medicine exactly as your doctor tells you to. Do not take more or less medicine than directed, and don’t stop taking Azmacort without discussing it with your doctor first.
If you miss a dose of this medicine, take it as soon as you remember, unless it is almost time for your next dose. Do NOT double doses.
Talk with your doctor immediately if any of the following side effects occur: shortness of breath, troubled breathing, tightness in chest, or wheezing; or signs of hypersensitivity reactions, such as swelling of face, lips, or eyelids.
Also, tell your doctor as soon as possible if any of the following side effects occur: bruising; burning or pain while urinating, blood in urine, or frequent urge to urinate; chest pain; creamy white, curd-like patches in the mouth or throat and/or pain when eating or swallowing; dizziness or sense of constant movement or surroundings; general feeling of discomfort or illness; irregular or fast heartbeat; itching, rash, or hives; sinus problems; stomach or abdominal pain; swelling of fingers, ankles, feet, or lower legs; unusual tiredness or weakness; or weight gain.
Triamcinolone acetonide, USP, the active ingredient in Azmacort® Inhalation Aerosol, is a corticosteroid with a molecular weight of 434.5 and with the chemical designation 9-Fluoro-11b , 16a , 17, 21-tetrahydroxypregna-1, 4-diene-3, 20-dione cyclic 16, 17-acetal with acetone. (C24H31FO6).Azmacort Inhalation Aerosol is a metered-dose aerosol unit containing a microcrystalline suspension of triamcinolone acetonide in the propellant dichlorodifluoromethane and dehydrated alcohol USP 1% w/w. Each canister contains 60 mg triamcinolone acetonide. The canister must be primed prior to the first use. After an initial priming of 2 actuations, each actuation delivers 200 mcg triamcinolone acetonide from the valve and 100 mcg from the spacer-mouthpiece under defined in vitro test conditions. The canister will remain primed for 3 days. If the canister is not used for more than 3 days, then it should be reprimed with 2 actuations. There are at least 240 actuations in one Azmacort Inhalation Aerosol canister. After 240 actuations, the amount delivered per actuation may not be consistent and the unit should be discarded.
The structural formula is: